Peter U Ardelt

Summary

Country: Germany

Publications

  1. doi Reactive antibodies against bacillus Calmette-Guerin heat-shock protein-65 potentially predict the outcome of immunotherapy for high-grade transitional cell carcinoma of the bladder
    Peter U Ardelt
    Department of Urology and Pediatric Urology, Bavarian Julius Maximilians University Medical School, Wurzburg, Germany
    Cancer 116:600-9. 2010
  2. pmc An anti-ubiquitin antibody response in transitional cell carcinoma of the urinary bladder
    Peter U Ardelt
    Department of Urology, University Hospital Basel, Basel, Switzerland Department of Urology and Pediatric Urology, Medical School, Albert Ludwigs University of Freiburg, Freiburg, Germany Department of Urology, Bavarian Julius Maximilians University Medical School, Wurzburg, Germany
    PLoS ONE 10:e0118646. 2015

Collaborators

Detail Information

Publications2

  1. doi Reactive antibodies against bacillus Calmette-Guerin heat-shock protein-65 potentially predict the outcome of immunotherapy for high-grade transitional cell carcinoma of the bladder
    Peter U Ardelt
    Department of Urology and Pediatric Urology, Bavarian Julius Maximilians University Medical School, Wurzburg, Germany
    Cancer 116:600-9. 2010
    ..The objectives of this study were to identify a marker for measuring the BCG-induced immune response and to predict the outcomes and potential improvements of BCG immunotherapy...
  2. pmc An anti-ubiquitin antibody response in transitional cell carcinoma of the urinary bladder
    Peter U Ardelt
    Department of Urology, University Hospital Basel, Basel, Switzerland Department of Urology and Pediatric Urology, Medical School, Albert Ludwigs University of Freiburg, Freiburg, Germany Department of Urology, Bavarian Julius Maximilians University Medical School, Wurzburg, Germany
    PLoS ONE 10:e0118646. 2015
    ..To use combinatorial epitope mapping ("fingerprinting") of the antibody response to identify targets of the humoral immune response in patients with transitional cell carcinoma (TCC) of the bladder...